Sjöberg Prize
Award
From Wikipedia, the free encyclopedia
The Sjöberg Prize is an award aimed at individuals or research groups that have made significant contributions to cancer research. The Sjöberg Prize is awarded as a partnership between the Royal Swedish Academy of Sciences and the Sjöberg Foundation. The Sjöberg Foundation also finances the prize. The Foundation was founded in 2016, and the first prize was announced in February 2017.[1]
| The Sjöberg Prize | |
|---|---|
| Awarded for | Significant contributions to cancer research |
| Country | Sweden |
| Presented by | Royal Swedish Academy of Sciences |
| First award | 2017 |
| Website | Swedish English |
The foundation was founded by businessman Bengt Sjöberg, who donated two billion Swedish kronor to promote scientific research, with the main focus on cancer, health and the environment.[1] The prize, which is international, is planned to be awarded annually. It consists of a 100,000 US dollars of free disposal and 900,000 dollars to fund future research making up a total of one million US dollars. The prize money increases to counteract inflation.[2]
Laureates
| Year | Image | Laureate | Nationality | Work | Ref. | |
|---|---|---|---|---|---|---|
| 2017 | .JPG) |
James P. Allison | American | “Pioneering studies of cellular processes which led to the development of new effective cancer drugs” | [2][3] | |
 |
Tony Hunter | British-American | ||||
| 2018 |  |
Zhu Chen | Chinese | “for the clarification of molecular mechanisms and the development of a revolutionary treatment for acute promyelocytic leukaemia” | [4] | |
 |
Anne Dejean | French | ||||
| Hugues de Thé | French | |||||
| 2019 | Dennis Slamon | American | “for their groundbreaking contributions to the clinical development of targeted therapy directed against genetic aberrations in cancer.” | [5] | ||
 |
Brian Druker | American | ||||
| 2020 |  |
Michael N. Hall | American | “for their discovery of mTOR and its role in the control of cell metabolism and growth.” | [6] | |
| David M. Sabatini | American | |||||
| 2021 | Benjamin L. Ebert | American | “for his discovery of the mode of action of lenalidomide in the treatment of haematological disorders” | [7] | ||
| 2022 | Arul Chinnaiyan | American | "for the discovery of recurrent gene fusions in prostate cancer" | [8] | ||
| 2023 | Kevan Shokat | American | “for discoveries that enable the inhibition of mutated K-Ras in cancer treatment” | [9] | ||
| 2024 | Catherine J. Wu | American | “for discoveries concerning tumour neoantigens and the immune response to tumour cells as a basis for cancer vaccine development” | [10] | ||
| 2025 | Miriam Merad | “for discoveries identifying the origin of myeloid cell subtypes and elucidating how they modulate antitumour immunity” | [11] | |||
| 2026 | Charles Swanton | British | "who has provided fundamental knowledge about evolution in tumours." | [12] |